Epidemiological situation of pertussis and strategies to control it. Argentina, 2002-2011;Situación epidemiológica de coqueluche y estrategias para su control. Argentina, 2002-2011

Archivos Argentinos de Pediatria

Volumn 112, Issue 5, 2014, Pages 413-420

  Romanin, Viviana ^a   Agustinho, Vanina ^a   Califano, Gloria ^a   Sagradini, Sandra ^a   Aquino, Analía ^a   Del Valle Juárez, María ^a   Antman, Julián ^b   Giovacchini, Carlos ^b   Galas, Marcelo ^c   Lara, Claudia ^c   Hozbor, Daniela ^d   Gentile, Ángela ^e   Vizzotti, Carla ^a  

^a Ministryof Health OfArgentina   (Argentina)

^b National Ministry of Health   (Argentina)

^c National Reference Laboratory for Pertussis   (Argentina)

^d UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^e Ministerio Salud de la Provincia de Buenos Aires   (Argentina)

Author keywords

Epidemiological surveillance; Pertussis; Pertussis immunization

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ARGENTINA; CHILD; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMAN; INCIDENCE; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; WHOOPING COUGH; ARTICLE; INFECTION CONTROL; PERTUSSIS;

ADOLESCENT; ARGENTINA; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 84985961650     PISSN: 03250075     EISSN: 16683501     Source Type: Journal    
DOI: 10.5546/aap.2014.eng.413     Document Type: Article

References (35)

1. American Academy of Pediatrics. Pertussis (Whooping Cough). En: Pickering LK, ed. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012. P.gs.553-66.
2. Sociedad Argentina de Pediatr.a. Comit. Nacional de Infectolog.a. Bordetella Pertussis. En: Libro Azul de Infectología Pediátrica. 4ta ed. Buenos Aires: SAP; 2012.P.gs.484-93.
3. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th ed. Washington DC: Public Health Foundation, 2012. Chapter 15 Pertussis. Available at: http://www.cdc.gov/vaccines/pubs/pinkbook/pert.html. [Accessed on: March 10, 2013].
4. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005;24(5 Suppl):S10-8.
5. World Health Organization. Immunization, Vaccines and Biologicals. Pertussis. Geneva: World Health Organization, 2012. Available at: http://www.who.int/immunization/topics/pertussis/en/index.html. [Accessed on: April 15, 2013].
6. Argentina. Ministerio de Salud de la Nación. Manual de normas y procedimientos de Vigilancia y Control de Enfermedades de Notificación Obligatoria. Revisión nacional 2007. Buenos Aires, 2007. Available at: http://www.msal.gov.ar/images/stories/epidemiologia/pdf/manual-normas-obligatorias.pdf. [Accessed on: April 20, 2013].
7. Argentina. Ministerio de Salud de la Nación. Vigilancia Clínica (C2). Buenos Aires, 2013. Available at: http://www.msal.gov.ar/index.php/home/funciones/area-devigilancia/snvs-c2. [Accessed on: April 20, 2013].
8. Argentina. Ministerio de Salud de la Nación. SIVILA. Sistema Nacional de Vigilancia Epidemiolígica por Laboratorios de Argentina. Buenos Aires, 2013. Available at: http://www.msal.gov.ar/index.php/home/funciones/area-de-vigilancia/sivila. [Accessed on: April 20, 2013].
9. Argentina. Ministerio de Salud de la Nación. Dirección de Estad.stica e Información en Salud. Defunciones de menores de 5 años. Indicadores seleccionados. Boletín número 139. Buenos Aires: Dirección de Estad.stica e Información en Salud; 2013. Available at: http://www.deis.gov.ar/publicaciones/Archivos/Boletin139.pdf. [Accessed on: June 9, 2014].
10. Argentina. Ministerio de Salud. Manual de Normas y Procedimientos del Sistema Nacional de Vigilancia Epidemiol.gica. SI.NA.VE. - 1999. Revisi.n Internacional 2000. Buenos Aires, 2000.
11. Argentina. Ministerio de Salud de la Nación. Programa Nacional de Control de Enfermedades Inmunoprevenibles. Actualización de la Situación de coqueluche. Alerta N. Buenos Aires, 2001.[Accessed on: June 18, 2014]. Available at: http://www.msal.gov.ar/images/stories/epidemiologia/inmunizaciones/alerta-sarampion/alertacoqueluche-Agosto19-5B1-5D.pdf
12. Argentina. Ministerio de Salud de la Nación. Coqueluche sospechoso y coqueluche en estudios de contactos: normativa y tutorial para la vigilancia a través del sistema nacional de vigilancia laboratorial. SIVILA-SNVS. Actualizaci.n 2011. Buenos Aires, 2011. Available at: http://www.msal.gov.ar/images/stories/epidemiologia/vigilancia/sivila/tutoriales/coqueluche-tutorialnormativa-para-notificacion-sivila-2011.pdf. [Accessed on: April 20, 2013].
13. World Health Organization. Immunization. Vaccines and Biologicals. Laboratory manual for the diagnosis of whooping cough caused by Bordetella pertussis/Bordetella parapertussis. Geneva: World Health Organization, 2007. Available at: http://whqlibdoc.who.int/hq/2004/WHO-IVB-04.14-eng.pdf. [Accessed on: March 10, 2013].
14. Glare EM, Paton JC, Premier RR, Lawrence AJ, et al. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction. J Clin Microbiol 1990;28(9):1982-7.
15. Grimprel E, B.gu. P, Anjak I, Betsou F, et al. Comparison of polymerase chain reaction, culture, and western immunoblot serology for diagnosis of Bordetella pertussis infection. J Clin Microbiol 1993;31(10):2745-50.
16. Tatti KM, Sparks KN, Boney KO, Tondella ML. Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. J Clin Microbiol 2011;49(12):4059-66.
17. Adams DA, Gallagher KM, Jajosky RA, Kriseman J, et al. Summary of Notifiable Diseases - United States, 2011. MMWR Morb Mortal Wkly Rep 2013;60(53):1-117.
18. Plotkin S. Aims, scope and findings of the global pertussis initiative. Pediatr Infect Dis J 2005;24(5 Suppl):S5-6.
19. Halperin SA. The control of pertussis - 2007 and beyond. N Eng J Med 2007;356(2):110-3.
20. Winter K, Harriman K, Zipprich J, Schechter R, et al. California pertussis epidemic, 2010. J Pediatr 2012;161(6):1091-6.
21. Centers for Disease Control and Prevention (CDC). Pertussis epidemic-Washington, 2012. MMWR Morb Mortal Wkly Rep 2012;61(28):517-22.
22. Chile. Ministerio de Salud. Departamento de Epidemiolog.a. Informe de coqueluche a.o 2011. Santiago de Chile, 2011. Available at: http://epi.minsal.cl/epi/html/bolets/reportes/Coqueluche/Tos-Final-2011.pdf. [Accessed on: March 25, 2013].
23. Uruguay. Ministerio de Salud P.blica. Direcci.n General de la Salud, Divisi.n de Epidemiolog.a. Informe de actualizaci.n. Situaci.n tos convulsa (a la semana epidemiol.gica 37 de 2012). Montevideo: Ministerio de Salud P.blica; 2012. Available at: http://www.msp.gub.uy/sites/default/files/archivos-Adjuntos/Informe-tos-convulsa-SETIEMBRE-2012%20(4).pdf. [Accessed on: June 9, 2014].
24. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, et al. Trends in pertussis among infants in the United States, 1980-1999. JAMA 2003;290(22):2968-75.
25. Cherry JD, Grimpel E, Guiso N, Heininger U, et al. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005;24(5 Suppl):S25-34.
26. Heininger U, Schmidt-Schl.pfer G, Cherry JD, Stehr K. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 2000;105(3):E31.
27. Giammanco A, Nardone A, Pebody R, Kafatos G, et al. European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations. Vaccine 2008;26(35):4486-93.
28. World Health Organization. Estimates of disease burden and cost-effectiveness. Geneva: World Health Organization: 2014. Available at: http://www.who.int/immunization/monitoring-surveillance/burden/estimates/en/.[Accessed on: June 9, 2014].
29. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60(41):1424-6.
30. Leuridan E, Hens N, Peeters N, de Witte L, et al. Effect of a pregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011;30(7):608-10.
31. Argentina. Ministerio de Salud de la Nación, Programa Nacional de Control de Enfermedades Inmunoprevenibles. Alerta epidemiol.gico 25/1/2012. Tos convulsa: aumento de casos y muertes. Buenos Aires; 2012. Available at: http://www.msal.gov.ar/images/stories/bes/graficos/0000000454cnt-2013-10-Alerta-n01-tosconvulsa-2012.pdf. [Accessed on: June 9, 2014].
32. Argentina. Ministerio de Salud de la Naci.n. Calendario Nacional de Vacunaci.n de la Rep.blica Argentina 2012. Buenos Aires; 2012. Available at: http://www.msal.gov.ar/images/stories/calendario-vacunacion/calendariovacunacion-2012.pdf. [Accessed on: June 9, 2014].
33. Argentina. Ministerio de Salud de la Naci.n, Secretar.a de Promoci.n y Programas Sanitarios. Normas nacionales de vacunaci.n. Edici.n 2008. Buenos Aires: OPS/OMS Argentina; 2008. Available at: http://publicaciones.ops.org.ar/publicaciones/otras%20pub/Normas-Nacionalesde-Vacunacion-2008.pdf. [Accessed on: June 9, 2014].
34. Tartof SY, Lewis M, Kenyon C, White K, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013;131(4):e1047-52.
35. Fingermann M, Fern.ndez J, Sisti F, Rodr.guez ME, et al. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine 2006;24(17):3513-21.